Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2017000085) APPLICATIONS OF SUNLIDAC IN PREPARATION OF PRODUCTS FOR RESISTING AGAINST LUNG CANCER
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/2017/000085 International Application No.: PCT/CN2015/000480
Publication Date: 05.01.2017 International Filing Date: 30.06.2015
IPC:
A61K 31/192 (2006.01) ,A61P 35/04 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
185
Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
19
Carboxylic acids, e.g. valproic acid
192
having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
35
Antineoplastic agents
04
specific for metastasis
Applicants:
上海交通大学 SHANGHAI JIAO TONG UNIVERSITY [CN/CN]; 中国上海市 徐汇区华山路1954号 1954 Huashan Road, Xuhui Shanghai 200030, CN
Inventors:
师咏勇 SHI, Yongyong; CN
宋智健 SONG, Zhijian; CN
Agent:
北京纪凯知识产权代理有限公司 JEEKAI & PARTNERS; 中国北京市 丰台广安路9号5号楼15A层 Floor 15A Building No. 5, 9 Guang'an Road, Fengtai Beijing 100055, CN
Priority Data:
Title (EN) APPLICATIONS OF SUNLIDAC IN PREPARATION OF PRODUCTS FOR RESISTING AGAINST LUNG CANCER
(FR) UTILISATION DE SUNLIDAC DANS LA PRÉPARATION D'UN PRODUIT DE LUTTE CONTRE LE CANCER DU POUMON
(ZH) Sunlidac在制备抗肺癌产品中的应用
Abstract:
(EN) Disclosed are applications of Sunlidac in the preparation of products for treating lung cancer or prohibiting lung cancer cells, wherein the lung cancer cells are NCI-H720 or SW900, and the products are drugs or reagent kits.
(FR) La présente invention porte sur l'utilisation de sunlidac dans la préparation d'un produit indiqué pour le traitement du cancer du poumon ou pour l'inhibition de la prolifération de cellules anormales entraînant le cancer du poumon, lesquelles cellules cancéreuses sont NCI-H720 ou SW900, le produit de la présente invention étant un médicament ou une trousse d'analyse.
(ZH) 本发明公开了sunlidac在制备治疗肺癌或抑制肺癌细胞增殖的产品中的应用,所述肺癌细胞为NCI-H720或SW900,所述产品为药物或试剂盒。
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: Chinese (ZH)
Filing Language: Chinese (ZH)
Also published as:
US20180185310